Comparison of a UL111a real‐time PCR and pp65 antigenemia for the detection of cytomegalovirus

Surveillance of cytomegalovirus (CMV) replication in transplant patients is crucial for the success of transplantation. To compare a CMV pp65 antigenemia (pp65Ag) and a quantitative real‐time PCR targeting the CMV‐UL111a (UL111aPCR), all whole blood samples taken between July 2008 and October 2009 were identified which had been analyzed prospectively by both assays in parallel. Discordant results were re‐analyzed using a published CMV duplex PCR targeting regions UL55 and UL123exon4. Of 720 samples from 81 transplant patients, CMV replication was detected in 244 specimens (34%) by the UL111aPCR (median, 1,019 geq/ml), compared to 113 (16%) detected by the pp65Ag (median, 2/250,000 leukocytes). Concordant UL111aPCR/pp65Ag results were obtained in 561 (78%) samples, being positive in 99 (14%), and negative in 462 (64%). As a rule of thumb, 1 pp65Ag‐positive cell per 250,000 leukocytes corresponded to 1,000 geq/ml CMV DNA of whole blood. Discordant results were found in 159 samples (22%), being UL111aPCR‐positive/pp65Ag‐negative in 145 (91%; median, 650 geq/ml), or UL111aPCR‐negative/pp65Ag‐positive in 14 (9%; median, 1/250,000 cells). Using the duplex PCR targeting the CMV UL55 and the UL123‐exon4 genes, 131 of 139 (94%) discordant UL111aPCR‐positives (median UL111aPCR, 639 geq/ml; median UL55PCR, 715 geq/ml; median UL123PCR, 1,103 geq/ml) were confirmed. Of 14 discordant pp65Ag‐positives, duplex PCR was also negative in 8, and of low copy number in 6. Thus, CMV UL111aPCR provides more sensitive quantitation of CMV replication than pp65Ag, however, discordant results can occur at very low viral loads. J. Med. Virol. 83:2143–2150, 2011. © 2011 Wiley Periodicals, Inc.

[1]  C. Kotton Management of cytomegalovirus infection in solid organ transplantation , 2010, Nature Reviews Nephrology.

[2]  H. Hirsch,et al.  Viral impact on long-term kidney graft function. , 2010, Infectious disease clinics of North America.

[3]  K. St. George,et al.  Relationship of cytomegalovirus load assessed by real-time PCR to pp65 antigenemia in organ transplant recipients. , 2008, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[4]  I. Binet,et al.  Cytomegalovirus-specific T-cell responses and viral replication in kidney transplant recipients , 2008, Journal of Translational Medicine.

[5]  C. Mengelle,et al.  Multicentric evaluation of a new commercial cytomegalovirus real-time PCR quantitation assay. , 2007, Journal of virological methods.

[6]  Hans H Hirsch,et al.  Viral dynamics in transplant patients: implications for disease. , 2007, The Lancet. Infectious diseases.

[7]  A. Lankester,et al.  Assessment of disseminated adenovirus infections using quantitative plasma PCR in adult allogeneic stem cell transplant recipients receiving reduced intensity or myeloablative conditioning , 2007, European journal of haematology.

[8]  L. Folgueira,et al.  Comparison of cytomegalovirus viral load measure by real-time PCR with pp65 antigenemia for the diagnosis of cytomegalovirus disease in solid organ transplant patients. , 2005, Transplantation proceedings.

[9]  J. Córdoba,et al.  Comparison of quantitative PCR and antigenemia in cytomegalovirus infection in renal transplant recipients. , 2005, Transplantation proceedings.

[10]  D. Saitovitch,et al.  Cytomegalovirus disease latent and active infection rates during the first trimester after kidney transplantation. , 2004, Transplantation proceedings.

[11]  E. Claas,et al.  Validation of Clinical Application of Cytomegalovirus Plasma DNA Load Measurement and Definition of Treatment Criteria by Analysis of Correlation to Antigen Detection , 2004, Journal of Clinical Microbiology.

[12]  T. Stevens-Ayers,et al.  Optimization of Quantitative Detection of Cytomegalovirus DNA in Plasma by Real-Time PCR , 2004, Journal of Clinical Microbiology.

[13]  F. Baldanti,et al.  Human cytomegalovirus immediate-early mRNAemia versus pp65 antigenemia for guiding pre-emptive therapy in children and young adults undergoing hematopoietic stem cell transplantation: a prospective, randomized, open-label trial. , 2003, Blood.

[14]  C. Rouzioux,et al.  Monitoring Cytomegalovirus Infection in Adult and Pediatric Bone Marrow Transplant Recipients by a Real-Time PCR Assay Performed with Blood Plasma , 2003, Journal of Clinical Microbiology.

[15]  P. Wright,et al.  Measurement of Human Cytomegalovirus Loads by Quantitative Real-Time PCR for Monitoring Clinical Intervention in Transplant Recipients , 2003, Journal of Clinical Microbiology.

[16]  Thomas F. Smith,et al.  The clinical use of various blood compartments for cytomegalovirus (CMV) DNA quantitation in transplant recipients with CMV disease. , 2002, Transplantation.

[17]  Thomas F. Smith,et al.  Role of the Laboratory in Diagnosis and Management of Cytomegalovirus Infection in Hematopoietic Stem Cell and Solid-Organ Transplant Recipients , 2002, Journal of Clinical Microbiology.

[18]  M. Wills,et al.  Latency and reactivation of human cytomegalovirus. , 2002, The Journal of infection.

[19]  J. Bourhis,et al.  Quantification of Human Cytomegalovirus DNA in Bone Marrow Transplant Recipients by Real-Time PCR , 2001, Journal of Clinical Microbiology.

[20]  M. Lappalainen,et al.  Comparison of plasma polymerase chain reaction and pp65-antigenemia assay in the quantification of cytomegalovirus in liver and kidney transplant patients. , 2001, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[21]  M. Mihatsch,et al.  CYTOMEGALOVIRUS INFECTION AND GRAFT REJECTION IN RENAL TRANSPLANTATION , 2001, Transplantation.

[22]  J. Nicolas,et al.  Quantification of Human Cytomegalovirus DNA by Real-Time PCR , 2001, Journal of Clinical Microbiology.

[23]  S. Ogawa,et al.  Real-Time Automated PCR for Early Diagnosis and Monitoring of Cytomegalovirus Infection after Bone Marrow Transplantation , 2000, Journal of Clinical Microbiology.

[24]  M. Boeckh,et al.  Quantitation of Cytomegalovirus: Methodologic Aspects and Clinical Applications , 1998, Clinical Microbiology Reviews.

[25]  D. Altman,et al.  STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT , 1986, The Lancet.

[26]  A. Beckett,et al.  AKUFO AND IBARAPA. , 1965, Lancet.

[27]  R. Razonable,et al.  Viral infections in transplant recipients. , 2009, Minerva medica.

[28]  和昭 薬師寺 Monitoring of cytomegalovirus reactivation after allogeneic stem cell transplantation : comparison of an antigenemia assay and quantitative real-time polymerase chain reaction , 2005 .

[29]  N. Kinukawa,et al.  Monitoring of cytomegalovirus reactivation after allogeneic stem cell transplantation: comparison of an antigenemia assay and quantitative real-time polymerase chain reaction , 2002, Bone Marrow Transplantation.

[30]  M. van der Giessen,et al.  Cytomegalovirus antigenemia. , 1990, Reviews of infectious diseases.